当前位置:首页 - 行情中心 - 禾元生物-U(688765) - 财务分析 - 现金流量表

禾元生物-U

(688765)

  

流通市值:25.49亿  总市值:196.88亿
流通股本:4628.00万   总股本:3.58亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金15,065,358.0156,017,967.124,014,868.569,076,565.82
  收到的税费返还93,543.561,107,161.41,025,084.9773,842.52
  收到其他与经营活动有关的现金4,135,658.497,027,306.7270,396,274.1258,181,911.33
  经营活动现金流入小计19,294,559.97154,152,435.2295,436,227.6567,332,319.67
  购买商品、接受劳务支付的现金34,883,707.0668,688,600.2475,359,601.9829,203,644.64
  支付给职工以及为职工支付的现金20,523,576.6251,027,056.9937,213,504.8424,566,949.56
  支付的各项税费1,730,099.032,207,161.131,581,861.81952,678.35
  支付其他与经营活动有关的现金11,680,389.85160,548,582.24100,151,154.3468,604,346.18
  经营活动现金流出小计68,817,772.56282,471,400.6214,306,122.97123,327,618.73
  经营活动产生的现金流量净额-49,523,212.59-128,318,965.38-118,869,895.32-55,995,299.06
二、投资活动产生的现金流量:
  收回投资收到的现金75,000,000---
  投资活动现金流入的平衡项目0---
  投资活动现金流入小计75,000,000---
  购建固定资产、无形资产和其他长期资产支付的现金233,847,042.4538,058,635.46331,602,803.67268,999,470.62
  投资支付的现金-1,310,830,000--
  投资活动现金流出小计233,847,042.41,848,888,635.46331,602,803.67268,999,470.62
  投资活动产生的现金流量净额-158,847,042.4-1,848,888,635.46-331,602,803.67-268,999,470.62
三、筹资活动产生的现金流量:
  吸收投资收到的现金-2,456,908,042.2--
  取得借款收到的现金24,900,000411,587,096.13406,587,096.13314,255,951.78
  筹资活动现金流入小计24,900,0002,868,495,138.33406,587,096.13314,255,951.78
  偿还债务支付的现金83,253,227.98321,809,094.4723,512,424.034,337,424.03
  分配股利、利润或偿付利息支付的现金1,933,586.6914,495,870.0610,012,885.645,558,097.25
  支付其他与筹资活动有关的现金2,060,00045,915,781.718,150,707.817,346,280
  筹资活动现金流出小计87,246,814.67382,220,746.2441,676,017.4817,241,801.28
  筹资活动产生的现金流量净额-62,346,814.672,486,274,392.09364,911,078.65297,014,150.5
四、汇率变动对现金及现金等价物的影响239.62-27,873.47-22,430.7-52,556.5
五、现金及现金等价物净增加额-270,716,830.04509,038,917.78-85,584,051.04-28,033,175.68
  加:期初现金及现金等价物余额669,441,252.44160,402,334.66160,402,334.66160,402,334.66
  期末现金及现金等价物余额398,724,422.4669,441,252.4474,818,283.62132,369,158.98
补充资料:
  净利润--157,037,347.83--81,627,815.84
  资产减值准备-705,891.77-368,217.96
  固定资产和投资性房地产折旧-59,075,705.14-29,320,657.64
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-59,075,705.14-29,320,657.64
  无形资产摊销-2,802,836.08-1,672,311.94
  长期待摊费用摊销-723,013.23-359,781.28
  处置固定资产、无形资产和其他长期资产的损失--3,788,302.22--2,463,090.15
  财务费用-7,559,677.76-3,739,831.76
  投资损失--907,526.05--
  存货的减少--73,339,498.69--30,610,246.26
  经营性应收项目的减少--77,559,983.99--21,655,757.72
  经营性应付项目的增加-86,510,149.25-32,029,061.36
  其他-23,156,127.89-11,187,284.45
  现金的期末余额-669,441,252.44-132,369,158.98
  减:现金的期初余额-160,402,334.66-160,402,334.66
  现金及现金等价物的净增加额-509,038,917.78--28,033,175.68
公告日期2026-04-282026-04-282025-10-242025-09-23
审计意见(境内)标准无保留意见标准无保留意见
TOP↑